Filtered By:
Cancer: Prostate Cancer
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 25217 results found since Jan 2013.
Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostate biopsies
Asian J Androl. 2023 Aug 22. doi: 10.4103/aja202332. Online ahead of print.ABSTRACTWe aim to evaluate prostate health index as an additional risk-stratification tool in patients with Prostate Imaging Reporting and Data System score 3 lesions on multiparametric magnetic resonance imaging. Men with biochemical or clinical suspicion of having prostate cancer who underwent multiparametric magnetic resonance imaging in two tertiary centers (Queen Mary Hospital and Princess Margaret Hospital, Hong Kong, China) between January 2017 and June 2022 were included. Ultrasound-magnetic resonance imaging fusion biopsies were performed a...
Source: Asian Journal of Andrology - September 11, 2023 Category: Urology & Nephrology Authors: John Shung-Lai Leung Wai-Kit Ma Brian Sze-Ho Ho Stacia Tsun-Tsun Chun Rong Na Yongle Zhan Chi-Yuen Ng Chi-Ho Ip Ada Tsui-Lin Ng Yiu-Chung Lam Source Type: research
Growing Deficit in New Cancer Diagnoses 2 Years Into the COVID-19 Pandemic: A National Multicenter Study
CONCLUSION: Disruptions in new diagnoses of four common cancers (prostate, lung, bladder, and colorectal) seen early in the COVID-19 pandemic have persisted for 2 years. Although reductions improved from the early pandemic, new reductions during the Delta and Omicron waves demonstrate the continued impact of the COVID-19 pandemic on cancer care.PMID:37695458 | DOI:10.1245/s10434-023-14217-5
Source: Ann Oncol - September 11, 2023 Category: Cancer & Oncology Authors: Brian R Englum Shalini Sahoo Minerva Mayorga-Carlin Hilary Hayssen Tariq Siddiqui Douglas J Turner John D Sorkin Brajesh K Lal Source Type: research
Global efficacy and clinical application of androgen receptor inhibitors in metastatic prostate cancer
Chin Clin Oncol. 2023 Sep 6:cco-23-59. doi: 10.21037/cco-23-59. Online ahead of print.NO ABSTRACTPMID:37691348 | DOI:10.21037/cco-23-59
Source: Ann Oncol - September 11, 2023 Category: Cancer & Oncology Authors: Ulka Vaishampayan Source Type: research
Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR
This article also emphasized the recent advances in the field of medicinal chemistry of prostate cancer agents.PMID:37694781 | DOI:10.2174/1389557523666230911141339
Source: Mini Reviews in Medicinal Chemistry - September 11, 2023 Category: Chemistry Authors: Manish Chaudhary Shubham Kumar Paranjeet Kaur Sanjeev Kumar Sahu Amit Mittal Source Type: research
Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostate biopsies
Asian J Androl. 2023 Aug 22. doi: 10.4103/aja202332. Online ahead of print.ABSTRACTWe aim to evaluate prostate health index as an additional risk-stratification tool in patients with Prostate Imaging Reporting and Data System score 3 lesions on multiparametric magnetic resonance imaging. Men with biochemical or clinical suspicion of having prostate cancer who underwent multiparametric magnetic resonance imaging in two tertiary centers (Queen Mary Hospital and Princess Margaret Hospital, Hong Kong, China) between January 2017 and June 2022 were included. Ultrasound-magnetic resonance imaging fusion biopsies were performed a...
Source: Asian Journal of Andrology - September 11, 2023 Category: Urology & Nephrology Authors: John Shung-Lai Leung Wai-Kit Ma Brian Sze-Ho Ho Stacia Tsun-Tsun Chun Rong Na Yongle Zhan Chi-Yuen Ng Chi-Ho Ip Ada Tsui-Lin Ng Yiu-Chung Lam Source Type: research
Global efficacy and clinical application of androgen receptor inhibitors in metastatic prostate cancer
Chin Clin Oncol. 2023 Sep 6:cco-23-59. doi: 10.21037/cco-23-59. Online ahead of print.NO ABSTRACTPMID:37691348 | DOI:10.21037/cco-23-59
Source: Clinical Prostate Cancer - September 11, 2023 Category: Cancer & Oncology Authors: Ulka Vaishampayan Source Type: research
Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostate biopsies
Asian J Androl. 2023 Aug 22. doi: 10.4103/aja202332. Online ahead of print.ABSTRACTWe aim to evaluate prostate health index as an additional risk-stratification tool in patients with Prostate Imaging Reporting and Data System score 3 lesions on multiparametric magnetic resonance imaging. Men with biochemical or clinical suspicion of having prostate cancer who underwent multiparametric magnetic resonance imaging in two tertiary centers (Queen Mary Hospital and Princess Margaret Hospital, Hong Kong, China) between January 2017 and June 2022 were included. Ultrasound-magnetic resonance imaging fusion biopsies were performed a...
Source: Asian Journal of Andrology - September 11, 2023 Category: Urology & Nephrology Authors: John Shung-Lai Leung Wai-Kit Ma Brian Sze-Ho Ho Stacia Tsun-Tsun Chun Rong Na Yongle Zhan Chi-Yuen Ng Chi-Ho Ip Ada Tsui-Lin Ng Yiu-Chung Lam Source Type: research
Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR
This article also emphasized the recent advances in the field of medicinal chemistry of prostate cancer agents.PMID:37694781 | DOI:10.2174/1389557523666230911141339
Source: Mini Reviews in Medicinal Chemistry - September 11, 2023 Category: Chemistry Authors: Manish Chaudhary Shubham Kumar Paranjeet Kaur Sanjeev Kumar Sahu Amit Mittal Source Type: research
Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostate biopsies
Asian J Androl. 2023 Aug 22. doi: 10.4103/aja202332. Online ahead of print.ABSTRACTWe aim to evaluate prostate health index as an additional risk-stratification tool in patients with Prostate Imaging Reporting and Data System score 3 lesions on multiparametric magnetic resonance imaging. Men with biochemical or clinical suspicion of having prostate cancer who underwent multiparametric magnetic resonance imaging in two tertiary centers (Queen Mary Hospital and Princess Margaret Hospital, Hong Kong, China) between January 2017 and June 2022 were included. Ultrasound-magnetic resonance imaging fusion biopsies were performed a...
Source: Asian Journal of Andrology - September 11, 2023 Category: Urology & Nephrology Authors: John Shung-Lai Leung Wai-Kit Ma Brian Sze-Ho Ho Stacia Tsun-Tsun Chun Rong Na Yongle Zhan Chi-Yuen Ng Chi-Ho Ip Ada Tsui-Lin Ng Yiu-Chung Lam Source Type: research
Dominant negative TGF β receptor II and truncated TIM3 enhance the antitumor efficacy of CAR-T-cell therapy in prostate cancer
CONCLUSIONS: This study emphasizes that upregulating dnTGFβRII and trTIM3 on the surface of T cells can potentially diminish the inhibitory effects of TGFβRII and TIM3.PMID:37690238 | DOI:10.1016/j.intimp.2023.110807
Source: International Immunopharmacology - September 10, 2023 Category: Allergy & Immunology Authors: Lei Tang Huimin Shao Yao Wu Jiawei Wang Xueyi Qian Lianjun He Houbao Huang Zhenyu Xu Source Type: research
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites
CONCLUSION: In mPCa patients, lung only visceral metastases, especially when associated with lymph node only nonvisceral metastases, portend the best prognosis. Conversely, visceral metastatic sites other than lung portend poor prognosis, regardless of concomitant nonvisceral metastases type.PMID:37690970 | DOI:10.1016/j.clgc.2023.08.004
Source: Clinical Prostate Cancer - September 10, 2023 Category: Cancer & Oncology Authors: Stefano Tappero Mattia Luca Piccinelli Reha-Baris Incesu Cristina Cano Garcia Francesco Barletta Simone Morra Lukas Scheipner Andrea Baudo Zhe Tian Stefano Parodi Paolo Dell'Oglio Ottavio de Cobelli Markus Graefen Felix K H Chun Alberto Briganti Nicola Lo Source Type: research
